Streetbeat News

Stock Prices

EURN

FRO

Stifel analyst Benjamin J. Nolan downgraded Euronav NV (EURN) to Hold from Buy with a lowered price target of $18.43. This follows the offer by Compagnie Maritime Belge (CMB) to acquire Frontline Plc's (FRO) 26.12% stake in EURN. The deal also involves FRO acquiring 24 VLCC tankers from EURN's fleet. Post closure, CMB will own 49.05% of EURN's outstanding shares and is expected to make a mandatory public takeover offer. Nolan expects EURN to become private in the coming quarters.

Portfolio Pulse from Lekha Gupta

October 10, 2023 | 7:17 pm

TGT

Target's (NYSE:TGT) short percent of float has decreased by 4.64% since its last report, with 8.50 million shares sold short, representing 1.85% of all regular shares available for trading. It would take traders 2.58 days to cover their short positions on average. Compared to its peers, Target has less short interest as a percentage of float, with the average being 3.73%.

Portfolio Pulse from Benzinga Insights

October 10, 2023 | 7:15 pm

SPY

Federal Reserve Bank of Minneapolis President Neel Kashkari has stated that inflation is likely to decrease. This statement could influence the overall market sentiment.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2023 | 7:12 pm

GLD

SPY

Despite growing market uncertainty, investors are selling gold at a historic rate, with Gold's relative strength index hitting a level seen less than 1% of the time since 1971. The SPDR Gold Trust (GLD) has seen a slight increase recently, but is down more than 6% in the last six months. In contrast, the SPDR S&P 500 Trust ETF (SPY) is up more than 6% in the same period. Some investors are opting for treasury bonds that offer around 5% yield and are virtually risk-free.

Portfolio Pulse from Aaron Bry

October 10, 2023 | 7:07 pm

LLY

NVS

RYZB

JP Morgan has initiated coverage on RayzeBio Inc (NASDAQ:RYZB), a company in the radiopharmaceutical space, with an Outperform rating and a price target of $30. The analysts see potential value-creating milestones over the next 2+ years for RayzeBio. The radiopharmaceutical landscape includes notable therapies like Novartis AG's (NYSE:NVS) Lutathera and Pluvicto. The planned acquisition of POINT Biopharma by Eli Lilly And Co (NYSE:LLY) signals the potential attraction of more prominent entities to this advancing field.

Portfolio Pulse from Vandana Singh

October 10, 2023 | 7:06 pm

DE

A significant bullish stance has been taken on Deere (NYSE:DE) by a large investor, as indicated by a large position in the company's options. The sentiment among these big-money traders is split between 57% bullish and 42% bearish. The whales have been targeting a price range from $370.0 to $430.0 for Deere over the last 3 months. Canaccord Genuity, HSBC, and Evercore ISI Group have downgraded their actions on Deere with price targets of $400, $486, and $424 respectively.

Portfolio Pulse from Benzinga Insights

October 10, 2023 | 7:00 pm

MGA

Over the past 3 months, 13 analysts have published their opinion on Magna International (NYSE:MGA) stock. The average price target for the stock is $63.0, an increase of 2.82% from the previous average price target of $61.27. The majority of the analysts are indifferent about the stock with 10 out of 13 giving it a neutral rating.

Portfolio Pulse from Benzinga Insights

October 10, 2023 | 7:00 pm

SRT

StarTek, Inc. (NYSE:SRT) shares surged after the company announced an agreement to be acquired by funds managed by CSP Management Limited for $4.30 per share in cash. The all-cash transaction has a total enterprise value of approximately $217 million and total equity value of approximately $174 million. Trading of the stock was halted and then resumed early in Tuesday's session. The stock experienced above-average trading volume of 877,491 shares compared to its average volume of 31,152. Barrington Research analyst Christopher Howe downgraded StarTek from Outperform to Market Perform.

Portfolio Pulse from Ryan Gustafson

October 10, 2023 | 7:00 pm

AER

In the last quarter, AerCap Holdings (NYSE:AER) received four bullish analyst ratings, with no bearish or indifferent ratings. The average 12-month price target for the company has increased by 11.67% to $83.75, with a high of $90.00 and a low of $79.00.

Portfolio Pulse from Benzinga Insights

October 10, 2023 | 7:00 pm

CGC

Canopy Growth Corporation (NASDAQ:CGC) shares rose after the company announced it received EU GMP certification for its cannabis cultivation facility in Ontario. This certification allows the company to continue exporting medically certified cannabis to European and other global medical cannabis markets. The certification also marks the completion of Canopy's consolidation of its production footprint into two purpose-built sites.

Portfolio Pulse from Ryan Gustafson

October 10, 2023 | 6:59 pm